Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Krisztina Kormosoi Tóth"'
Autor:
Balázs Gieszer, Ferenc Rényi-Vámos, Ildikó Madurka, Tibor Bartók, László Mészáros, Nóra Schönauer, Áron Ghimessy, Krisztina Kormosoi Tóth, György Lang, Attila Farkas, Levente Fazekas, Balazs Dome, János Varga, Tamás Dancs, László Agócs, Levente Bogyó, Jenö Elek, Péter Radeczky, Kristóf Csende, Peter Jaksch, Klára Török, Ákos Kocsis
Publikováno v:
Transplantation Proceedings. 51:1258-1262
Background After its initial difficulties were overcome, lung transplantation became an accepted and effective treatment for end-stage lung disease. Patients can take part in almost all kinds of sports after lung transplantation, including high-altit
Autor:
Tamás Dancs, Nóra Schönauer, Ferenc Rényi-Vámos, Kristóf Csende, Áron Ghimessy, Balazs Dome, Balázs Gieszer, Klára Török, Ildikó Madurka, Levente Bogyó, Tibor Bartók, Attila Farkas, László Mészáros, Levente Fazekas, Péter Radeczky, Ákos Kocsis, László Agócs, Anikó Bohács, Krisztina Kormosoi Tóth, György Lang, Jenő Elek
Publikováno v:
Transplantation Proceedings. 51:1296-1298
Lung transplant is an effective way to treat many end-stage lung diseases. However, one of the main barriers of allograft organ transplant is still the immunologic rejection of transplanted tissue, which is a response of the HLA molecules. Rejection
Autor:
Tamás Dancs, Ákos Kocsis, Nóra Schönauer, Attila Farkas, Krisztina Kormosoi Tóth, György Lang, Shahrokh Taghavi, Klára Török, Kristóf Csende, Levente Fazekas, László Agócs, Levente Bogyó, Balazs Dome, Jenő Elek, Péter Radeczky, Áron Ghimessy, Balázs Gieszer, Ferenc Rényi-Vámos, Walter Klepetko, K. Hötzenecker, László Mészáros, Ildikó Madurka, Tibor Bartók
Publikováno v:
Transplantation proceedings. 51(4)
Introduction Lung transplantation is the only successful treatment option for patients experiencing end-stage lung disease. Results have improved significantly in the last decade; however, the number one limiting factor is still the shortage of donor